News

Video

Pearls for diagnosing lagophthalmos with exposure keratitis

Author(s):

According to Robert Latkany, MD, understanding the causes and recognizing these diagnostic features are essential for effective treatment.

In an interview with Ophthalmology Times, Robert Latkany, MD, a New York ocular surface specialist, discusses lagophthalmos, the inability to fully close the eyelids, often leads to exposure keratitis, causing irritation and damage to the ocular surface.

Common causes include individuals naturally sleeping with their eyes open, post-surgical changes from blepharoplasty or other eyelid surgeries, prolonged eye procedures weakening muscular function, neurological conditions like Bell’s palsy, age-related muscle decline, chronic eye rubbing from allergies, and thyroid eye disease, which pushes the eyeball forward, preventing proper eyelid closure.

Diagnosis involves observing blinking patterns and eyelid positioning, as incomplete blinking is a key indicator. Patients frequently report symptoms such as dryness, irritation, redness, or a burning sensation, particularly upon waking. Linear or lower corneal erosions identified through fluorescein staining during slit-lamp exams are strong diagnostic markers.

Lagophthalmos can be classified into three types: obvious, where the eyelids visibly fail to meet; overhang, where the upper eyelid appears closed but leaves a hidden gap; and functional, where subtle issues interfere with eyelid closure without apparent physical separation.

Understanding the causes and recognizing these diagnostic features are essential for effective treatment. Depending on severity and underlying conditions, management options include lubricants, surgical interventions, and other measures to protect the ocular surface and preserve vision health.

Related Videos
Lana Rifkin, MD, uveitis committee chair at EnVision Summit 2025
AAO 2024: Matt Giegengack, MD: Injectable endothelial cell therapy shows promise for improving vision and reducing glare in corneal edema
EyeCon 2024: Adam Wenick, MD, talks about myopic interventions across the lifespan
Adam Wenick, MD, chairs EyeCon session: New treatments in geographic atrophy from detection to intervention
EyeCon 2024: Laura M. Periman, MD, shares her passion for dry eye disease, discussing her surprising discovery of the Alpenglow Sign in Demodex blepharitis
David Eichenbaum, MD, presents advances in AMD therapy, highlights different mechanisms with a common goal
© 2025 MJH Life Sciences

All rights reserved.